|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
52016245
???header.onlineuser??? :
851
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.title???
|
Showing items 739001-739010 of 2348439 (234844 Page(s) Totally)
<< < 73896 73897 73898 73899 73900 73901 73902 73903 73904 73905 > >>
View [10|25|50] records per page
| 臺北醫學大學 |
2013 |
Rosiglitazone is Effective to Improve Renal Damage in Type-1-like Diabetic Rats
|
Huang, K-C;Cherng, Y-G;Chen, L-J;Hsu, C-T;Cheng, J-T |
| 國家衛生研究院 |
2013-08 |
Rosiglitazone is not associated with an increased risk of bladder cancer
|
Tseng, CH |
| 國立臺灣大學 |
2013 |
Rosiglitazone is not associated with an increased risk of bladder cancer
|
Tseng, Chin-Hsiao; 曾慶孝 |
| 國家衛生研究院 |
2015-02-06 |
Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese
|
Tseng, CH |
| 臺大學術典藏 |
2015 |
Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese
|
Tseng, C.-H.; CHIN-HSIAO TSENG |
| 臺大學術典藏 |
2020-06-01T08:33:31Z |
Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese
|
Chin-Hsiao Tseng; CHIN-HSIAO TSENG |
| 國家衛生研究院 |
2013-12 |
Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes
|
Tseng, CH |
| 國立臺灣大學 |
2013 |
Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes
|
Tseng, Chin-Hsiao; 曾慶孝 |
| 亞洲大學 |
2005 |
Rosiglitazone prevents h-IAPP induced islet cell apoptosis and the related loss of insulin secretion through the PPAR-r in human islets
|
林佳育;LIN, CY |
| 國家衛生研究院 |
2017-01 |
Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus
|
Tseng, CH |
Showing items 739001-739010 of 2348439 (234844 Page(s) Totally)
<< < 73896 73897 73898 73899 73900 73901 73902 73903 73904 73905 > >>
View [10|25|50] records per page
|
